| Astellas Pharma AG - Betmiga 50 mg, Retardtabletten |
| 62755 | | 02 | | Betmiga 50 mg | | Retardtabletten | | G04BD12 | | Mirabegron | | 19.05.2014 | | |
|
| Composition |
| mirabegronum 50 mg, E 321, excipiens pro compresso obducto. |
| Packungsbestandteile |
| Delayed release tablets | | | | | | | | Active Agent | Dose |
|---|
| Mirabegronum | 50 mg |
| | BAG: Active Agent | Dose |
|---|
| Mirabegronum | 50 mg |
| | | | |
|
|
